Editorial: Drug Hypersensitivity: From Mechanisms to Improved Diagnosis and Standards of Care

Fernandez, T. D.; Torres, M. J.; Romano, A.

Publication:
Editorial: Drug Hypersensitivity: From Mechanisms to Improved Diagnosis and Standards of Care

dc.contributor.author	Fernandez, T. D.
dc.contributor.author	Torres, M. J.
dc.contributor.author	Romano, A.
dc.contributor.authoraffiliation	[Fernandez,TD; Torres,MJ] Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain. [Fernandez,TD] Departamento de Biología Celular, Genética y Fisiología, Universidad de Málaga-IBIMA, Málaga, Spain. [Torres,MJ] Allergy Unit, Hospital Regional Universitario de Málaga, Málaga, Spain. [Torres,MJ] Departamento de Medicina, Universidad de Málaga-IBIMA, Málaga, Spain. [Torres,MJ] Andalusian Centre for Nanomedicine and Biotechnology-BIONAND, Málaga, Spain. [Romano,A] IRCCS Oasi Maria S.S., Troina, Italy. [Romano,A] Fondazione Mediterranea G.B. Morgagni, Catania, Italy.
dc.date.accessioned	2022-03-03T09:42:59Z
dc.date.available	2022-03-03T09:42:59Z
dc.date.issued	2021-06-17
dc.description.abstract	Adverse drugs reactions occur in 10–15% of hospitalized patients and cause 3–6% of hospital admissions, constituting adn important public health issue (Doña et al., 2012). Some of them are unpredictable and occur after exposure to a drug at doses normally tolerated. These reactions, called drug hypersensitivity reactions (DHRs), can be immunologically mediated (allergic reactions) or non-immunologically mediated (non-allergic hypersensitivity reactions), which comprise most reactions induced by nonsteroidal anti-inflammatory drugs (NSAIDs) (Pichler, 2019).
dc.description.version	Yes	es_ES
dc.identifier.citation	Fernandez TD, Torres MJ, Romano A. Editorial: Drug Hypersensitivity: From Mechanisms to Improved Diagnosis and Standards of Care. Front. Pharmacol. 2021;12:718928.	es_ES
dc.identifier.doi	10.3389/fphar.2021.718928	es_ES
dc.identifier.essn	1663-9812
dc.identifier.pmc	PMC8245755
dc.identifier.pmid	34220526	es_ES
dc.identifier.uri	http://hdl.handle.net/10668/3459
dc.journal.title	Frontiers in Pharmacology
dc.language.iso	en
dc.page.number	3 p.
dc.provenance	Realizada la curación de contenido 26/03/2025
dc.publisher	Frontiers Research Foundation	es_ES
dc.relation.publisherversion	https://www.frontiersin.org/articles/10.3389/fphar.2021.718928/full	es_ES
dc.rights	Atribución 4.0 Internacional	*
dc.rights.accessRights	open access
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/	*
dc.subject	Drug	es_ES
dc.subject	Adverse reaction	es_ES
dc.subject	Hypersensitivity	es_ES
dc.subject	Diagnosis	es_ES
dc.subject	Management	es_ES
dc.subject.decs	Preparaciones farmacéuticas
dc.subject.decs	Hipersensibilidad
dc.subject.decs	Diagnóstico
dc.subject.decs	Salud Pública
dc.subject.decs	Glucosamina
dc.subject.mesh	Medical Subject Headings::Diseases::Chemically-Induced Disorders::Drug-Related Side Effects and Adverse Reactions	es_ES
dc.subject.mesh	Medical Subject Headings::Disciplines and Occupations::Health Occupations::Medicine::Allergy and Immunology::Immunochemistry	es_ES
dc.subject.mesh	Medical Subject Headings::Diseases::Chemically-Induced Disorders::Drug-Related Side Effects and Adverse Reactions::Drug Hypersensitivity	es_ES
dc.subject.mesh	Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans	es_ES
dc.subject.mesh	Medical Subject Headings::Health Care::Health Care Facilities, Manpower, and Services::Health Facilities::Hospitals::Hospitals, General	es_ES
dc.subject.mesh	Medical Subject Headings::Chemicals and Drugs::Biological Factors::Antigens::Epitopes	es_ES
dc.title	Editorial: Drug Hypersensitivity: From Mechanisms to Improved Diagnosis and Standards of Care	es_ES
dc.type	editorial
dc.type.hasVersion	VoR
dspace.entity.type	Publication